After Covishield, 1st batch of Bharat Biotech’s Covaxin arrives in Delhi

at 12:14 pm
Air India flight

New Delhi (NVI): The first consignment of ‘Covaxin’, the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech has reached the national capital on an Air India flight this morning.

The flight AI 559 transported the first batch from Hyderabad airport which landed at Delhi’s Indira Gandhi International (IGI) Airport at around 6:40 am.

According to the reports, the flight carrying three boxes of Covaxin weighing 80.5 kg, were then taken from Delhi to Haryana’s Kurukshetra, ahead of the January 16 nationwide vaccination drive launch.

This is the second day of vaccine transportation, after Pune-based Serum Institute of India (SII) shipped the first consignment of their COVID-19 vaccine ‘Covishield’ to 14 different locations across India.

The national capital also received a batch of vaccines from SII the same day, flown in the first flight of SpiceJet.

Bharat Biotech’s COVID-19 vaccine Covaxin will be sold at Rs 295 per dose in India. The company had arrived at a price agreement with the Indian government recently, the reports said.

The Center has also asked the Hyderabad-based company to supply around 55 lakh doses of its vaccine to 12 centres before January 14.

Earlier, to fight against the deadly contagion, the government of India granted emergency use to two vaccines — Covishield by Serum Institute of India and Covaxin developed by Bharat Biotech across the country.